1.
Bitonti R, Bozzari I, Cerutti E, Marcellusi A, Miranda A, Monterubbianesi R, et al. [Cost-Consequence Analysis of Vedolizumab Initiation Timing Strategies in Crohn’s Disease in Italy]. FE [Internet]. 2026 Mar. 25 [cited 2026 Jun. 25];27(1):21-33. Available from: https://journals.seedstm.com/index.php/FE/article/view/1605